THE SAFETY AND TOLERABILITY OF CYCLOSPORINE EMULSION VERSUS CYCLOSPORINE IN A RANDOMIZED, DOUBLE-BLIND COMPARISON IN PRIMARY RENAL ALLOGRAFT RECIPIENTS1

Autor: John S. Thompson, Donald E. Hricik, C. Martin Bunke, Mark D. Pescovitz, Raymond Pollak, M. Gerry Choc, David I. Min, Eva M. Vasquez, James B. Stinson, Judy Hyun Ju Jin, Jon B. Klein, Christopher L. Marsh, R. Wong, Duane G. Wombolt, Thomas Waid, Timothy L. Pruett, Gary Barone
Rok vydání: 1996
Předmět:
Zdroj: Transplantation. 61:968-970
ISSN: 0041-1337
DOI: 10.1097/00007890-199603270-00021
Popis: A 12-week, randomized, double-blind, multicenter pharmacokinetic study was conducted to compare the clinical safety and tolerability of cyclosporine capsules and oral solution for microemulsion and cyclosporine in 101 primary renal transplant recipients. Cyclosporine emulsion has more complete absorption and improved bioavailability compared with cyclosporine, and dosing of both cyclosporine formulations was adjusted to achieve comparable whole-blood trough levels. Mean serum creatinine values were higher in the cyclosporine emulsion group at baseline, 8, and 12 weeks (P
Databáze: OpenAIRE